Skip to content

Author

P. Gillard

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The Smart MDI System in People With Type 1 Diabetes and High HBA1C: A Randomized Controlled Trial Demonstrating That Response to Alerts Drives Outcomes.

AIMS The aim was to assess the efficacy and safety of the smart multiple daily injections (MDI) system versus MDI plus continuous glucose monitor (CGM) in people with Type 1 diabetes and HbA1c ≥ 8%. MATERIAL AND METHODS After a 3-week run-in, 143 participants were randomized to Smart MDI or MDI + CGM. The primary end...

Laurent Crenier, M. Haluzík, M. Lind et al. · 0 citations
Open access Sep 2026

Association between worsening time in range and microvascular complications in type 1 diabetes: real-world 5-year study.

CONTEXT Beyond HbA1c, continuous glucose monitoring (CGM) is now widely used in clinical practice, providing more detailed information about glycemic control. However, its ability to predict long-term microvascular outcomes in type 1 diabetes remains unclear. OBJECTIVE To evaluate the association between CGM-derived...

Amber Sabbe, N. Bochanen, A. Vandenbroucke et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.